Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.
Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Joseph Harvey
US contract development and manufacturing organization (CDMO) Tropichem Research Labs is building a non-sterile liquid facility in Montreal.
Industry groups have generally expressed support for the US FDA's new antimicrobial resistance (AMR) strategy.
Formed in 2017, Carus Animal Health is a UK-based business backed by Japan's largest animal health firm Kyoritsu Seiyaku. The new company has a mandate to stimulate innovation. Animal Pharm editor Joseph Harvey met Carus to explore its strategy for addressing unmet needs.
Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.
VakSea is in discussions with animal health companies concerning field trials in Asia of its natural immune-boosting protein derived from insect larva.
In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.